Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis are emerging worldwide. The Green Light Committee initiative supported programmatic management of drug-resistant tuberculosis in 90 countries. We used estimates from the Preserving Effective TB Treatment Study to predict MDR and XDR tuberculosis trends in four countries with a high burden of MDR tuberculosis: India, the Philippines, Russia, and South Africa.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Lancet Infect Dis

Title: The Lancet. Infectious diseases

Publisher: Elsevier BV

ISSN (Electronic): 1474-4457

ISSN (Print): 1473-3099

Publication date (Electronic): May 09 2017

Affiliations

[1 ] US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: asharma4@cdc.gov.

[2 ] US Centers for Disease Control and Prevention, Atlanta, GA, USA.

[3 ] South Africa Medical Research Council, Pretoria, South Africa.

[4 ] University of Maryland Medical Center, Baltimore, MD, USA.

[5 ] Tropical Disease Foundation, Manila, Philippines.

[6 ] Vladimir Oblast Tuberculosis Dispensary, Vladimir, Russia.

[7 ] Orel Oblast Tuberculosis Dispensary, Orel, Russia.

[8 ] Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow, Russia.

[9 ] Socios en Salud Sucursal, Lima, Peru.

[10 ] National Institute of Health, Lima, Peru.

[11 ] Riga East University Hospital Centre of Tuberculosis and Lung Diseases, Latvia.

[12 ] International Tuberculosis Research Center, Changwon and Yonsei University College of Medicine, Seoul, South Korea.

[13 ] Korean Institute of Tuberculosis, Seoul, South Korea.

[14 ] Tartu University Hospital, Tartu, Estonia.

[15 ] Ministry of Public Health, Bangkok, Thailand.

[16 ] Taiwan Centers for Disease Control, Taipei, Taiwan.

Article

Publisher Item ID: S1473-3099(17)30247-5

DOI: 10.1016/S1473-3099(17)30247-5

PubMed ID: 28499828

SO-VID: 4056e39a-961f-4bbc-bbdb-f1f0f88c9bc5

History

Data availability:

Comments

Comment on this article

scite_

Cited by 55

See all cited by

- Version 1
- Version 1